Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome

NO_LONGER_AVAILABLE

Conditions studied: Glucose Transporter 1 Deficiency Syndrome

In brief

This treatment plan is intended for the use of UX007 (triheptanoin) in the treatment of a single patient with Glucose Transporter 1 (GLUT1) Deficiency Syndrome.

Key facts

Study ID

NCT02968953

Run by

Jerry Vockley, MD, PhD

Last updated by the study team

2019-02-08

Who can join

Age: 3 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• This treatment plan is intended for the use of UX007 (triheptanoin) in the treatment of a single patient with Glucose Transporter 1 (GLUT1) Deficiency Syndrome.

You may not qualify if…

• Not applicable as study only includes one patient.

Where it is running

• Children's Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.